• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NAGNAG 受体位点的选择性剪接作为一种新的表型修饰物。

Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier.

机构信息

INSERM, Unité U955, Créteil, France.

出版信息

PLoS Genet. 2010 Oct 7;6(10):e1001153. doi: 10.1371/journal.pgen.1001153.

DOI:10.1371/journal.pgen.1001153
PMID:20949073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2951375/
Abstract

Approximately 30% of alleles causing genetic disorders generate premature termination codons (PTCs), which are usually associated with severe phenotypes. However, bypassing the deleterious stop codon can lead to a mild disease outcome. Splicing at NAGNAG tandem splice sites has been reported to result in insertion or deletion (indel) of three nucleotides. We identified such a mechanism as the origin of the mild to asymptomatic phenotype observed in cystic fibrosis patients homozygous for the E831X mutation (2623G>T) in the CFTR gene. Analyses performed on nasal epithelial cell mRNA detected three distinct isoforms, a considerably more complex situation than expected for a single nucleotide substitution. Structure-function studies and in silico analyses provided the first experimental evidence of an indel of a stop codon by alternative splicing at a NAGNAG acceptor site. In addition to contributing to proteome plasticity, alternative splicing at a NAGNAG tandem site can thus remove a disease-causing UAG stop codon. This molecular study reveals a naturally occurring mechanism where the effect of either modifier genes or epigenetic factors could be suspected. This finding is of importance for genetic counseling as well as for deciding appropriate therapeutic strategies.

摘要

大约 30%的导致遗传疾病的等位基因产生过早终止密码子(PTCs),通常与严重的表型相关。然而,绕过有害的终止密码子可能导致轻度疾病结果。已经报道了在 NAGNAG 串联剪接位点进行剪接会导致三个核苷酸的插入或缺失(indel)。我们发现这种机制是囊性纤维化患者中 CFTR 基因 E831X 突变(2623G>T)纯合子观察到的轻度至无症状表型的起源。对鼻上皮细胞 mRNA 的分析检测到三种不同的异构体,这比预期的单个核苷酸取代复杂得多。结构-功能研究和计算机分析提供了第一个通过 NAGNAG 受体位点的选择性剪接导致终止密码子插入缺失的实验证据。除了有助于蛋白质组可塑性外,NAGNAG 串联位点的选择性剪接还可以去除致病的 UAG 终止密码子。这项分子研究揭示了一种自然发生的机制,其中修饰基因或表观遗传因素的影响可能受到怀疑。这一发现对于遗传咨询以及决定适当的治疗策略都非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/060cb7494728/pgen.1001153.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/de01fb8bf53d/pgen.1001153.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/e6e3287df883/pgen.1001153.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/19b7bbd71329/pgen.1001153.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/87c64904fdf2/pgen.1001153.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/85d4e42e5914/pgen.1001153.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/060cb7494728/pgen.1001153.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/de01fb8bf53d/pgen.1001153.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/e6e3287df883/pgen.1001153.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/19b7bbd71329/pgen.1001153.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/87c64904fdf2/pgen.1001153.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/85d4e42e5914/pgen.1001153.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad1/2951375/060cb7494728/pgen.1001153.g006.jpg

相似文献

1
Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier.NAGNAG 受体位点的选择性剪接作为一种新的表型修饰物。
PLoS Genet. 2010 Oct 7;6(10):e1001153. doi: 10.1371/journal.pgen.1001153.
2
Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.详细分析囊性纤维化跨膜电导调节因子基因中反复出现的 c.1584+18672A>G 深内含子突变。
Am J Respir Cell Mol Biol. 2013 May;48(5):619-25. doi: 10.1165/rcmb.2012-0371OC.
3
Wobble splicing reveals the role of the branch point sequence-to-NAGNAG region in 3' tandem splice site selection.摆动剪接揭示了分支点序列到NAGNAG区域在3'串联剪接位点选择中的作用。
Mol Cell Biol. 2007 Aug;27(16):5835-48. doi: 10.1128/MCB.00363-07. Epub 2007 Jun 11.
4
Functional analysis of synonymous substitutions predicted to affect splicing of the CFTR gene.预测影响 CFTR 基因剪接的同义替换的功能分析。
J Cyst Fibros. 2012 Dec;11(6):511-7. doi: 10.1016/j.jcf.2012.04.009. Epub 2012 May 14.
5
Nucleotides in both donor and acceptor splice sites are responsible for choice in NAGNAG tandem splice sites.供体和受体剪接位点中的核苷酸负责 NAGNAG 串联剪接位点的选择。
Cell Mol Life Sci. 2021 Nov;78(21-22):6979-6993. doi: 10.1007/s00018-021-03943-2. Epub 2021 Oct 1.
6
Cystic fibrosis patients with the 3272-26A-->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane.携带3272-26A→G突变的囊性纤维化患者病情较轻,存在替代性mRNA剪接缺陷,且细胞膜上有囊性纤维化跨膜传导调节蛋白(CFTR)。
Hum Mutat. 1999;14(2):133-44. doi: 10.1002/(SICI)1098-1004(1999)14:2<133::AID-HUMU5>3.0.CO;2-T.
7
Alternative splicing of intron 23 of the human cystic fibrosis transmembrane conductance regulator gene resulting in a novel exon and transcript coding for a shortened intracytoplasmic C terminus.人类囊性纤维化跨膜传导调节基因内含子23的可变剪接,产生一个新的外显子和编码缩短的胞质内C末端的转录本。
J Biol Chem. 1993 Jan 5;268(1):686-90.
8
Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutations.CFTR基因的第9外显子:剪接位点单倍型与囊性纤维化突变
Hum Genet. 1994 Jan;93(1):67-73. doi: 10.1007/BF00218916.
9
Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing.NAGNAG受体中的单核苷酸多态性对可变剪接的变异具有高度预测性。
Am J Hum Genet. 2006 Feb;78(2):291-302. doi: 10.1086/500151. Epub 2005 Dec 22.
10
Identification and characterization of NAGNAG alternative splicing in the moss Physcomitrella patens.鉴定和描述Physcomitrella patens 中 NAGNAG 可变剪接。
BMC Plant Biol. 2010 Apr 28;10:76. doi: 10.1186/1471-2229-10-76.

引用本文的文献

1
Elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis harbouring two Class I variants: real-world data from the French compassionate programme.依列卡福妥-替扎卡福妥-依伐卡托治疗携带两个I类变异的囊性纤维化患者:来自法国同情用药项目的真实世界数据
EClinicalMedicine. 2025 Aug 30;88:103476. doi: 10.1016/j.eclinm.2025.103476. eCollection 2025 Oct.
2
Control of 3' Splice Site Selection in by a Highly Conserved Amino Acid within the Prp8 α-finger Domain.通过Prp8α-指结构域内一个高度保守的氨基酸对3'剪接位点选择的调控。
bioRxiv. 2025 Jun 20:2025.06.16.659908. doi: 10.1101/2025.06.16.659908.
3
Identified five variants in CFTR gene that alter RNA splicing by minigene assay.

本文引用的文献

1
Accurate prediction of NAGNAG alternative splicing.NAGNAG可变剪接的准确预测。
Nucleic Acids Res. 2009 Jun;37(11):3569-79. doi: 10.1093/nar/gkp220. Epub 2009 Apr 9.
2
Widespread and subtle: alternative splicing at short-distance tandem sites.广泛且细微:短距离串联位点处的可变剪接
Trends Genet. 2008 May;24(5):246-55. doi: 10.1016/j.tig.2008.03.003. Epub 2008 Apr 3.
3
Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis.基于精氨酸347诱变的CFTR(inh)-172对囊性纤维化跨膜传导调节因子(CFTR)直接抑制作用的证据。
通过小基因检测在CFTR基因中鉴定出5个改变RNA剪接的变体。
Front Genet. 2025 Mar 20;16:1543623. doi: 10.3389/fgene.2025.1543623. eCollection 2025.
4
SpliceAI-visual: a free online tool to improve SpliceAI splicing variant interpretation.SpliceAI-visual:一个免费的在线工具,用于改善 SpliceAI 剪接变异体解释。
Hum Genomics. 2023 Feb 10;17(1):7. doi: 10.1186/s40246-023-00451-1.
5
Identification of a Novel Canonical Splice Site Variant c.2967-1G>T That is Not Associated With Tuberous Sclerosis Pathogenesis.一种与结节性硬化症发病机制无关的新型典型剪接位点变异c.2967-1G>T的鉴定。
Front Genet. 2022 May 27;13:904224. doi: 10.3389/fgene.2022.904224. eCollection 2022.
6
Splicing mutations in the CFTR gene as therapeutic targets.CFTR 基因剪接突变作为治疗靶点。
Gene Ther. 2022 Aug;29(7-8):399-406. doi: 10.1038/s41434-022-00347-0. Epub 2022 Jun 2.
7
Personalized genetic counseling for Stargardt disease: Offspring risk estimates based on variant severity.基于变异严重程度的斯塔加特病个体化遗传咨询:后代风险估计。
Am J Hum Genet. 2022 Mar 3;109(3):498-507. doi: 10.1016/j.ajhg.2022.01.008. Epub 2022 Feb 3.
8
Nucleotides in both donor and acceptor splice sites are responsible for choice in NAGNAG tandem splice sites.供体和受体剪接位点中的核苷酸负责 NAGNAG 串联剪接位点的选择。
Cell Mol Life Sci. 2021 Nov;78(21-22):6979-6993. doi: 10.1007/s00018-021-03943-2. Epub 2021 Oct 1.
9
Genetics of agenesis/hypoplasia of the uterus and vagina: narrowing down the number of candidate genes for Mayer-Rokitansky-Küster-Hauser Syndrome.子宫和阴道发育不全/发育不良的遗传学:缩小 Mayer-Rokitansky-Küster-Hauser 综合征候选基因的数量。
Hum Genet. 2021 Apr;140(4):667-680. doi: 10.1007/s00439-020-02239-y. Epub 2021 Jan 19.
10
Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.评估外显子和内含子变异对 RNA 剪接的影响,可以准确评估精准治疗的效果。
PLoS Genet. 2020 Oct 21;16(10):e1009100. doi: 10.1371/journal.pgen.1009100. eCollection 2020 Oct.
Biochem J. 2008 Jul 1;413(1):135-42. doi: 10.1042/BJ20080029.
4
CSN5 binds to misfolded CFTR and promotes its degradation.CSN5与错误折叠的囊性纤维化跨膜传导调节因子(CFTR)结合并促进其降解。
Biochim Biophys Acta. 2008 Jun;1783(6):1189-99. doi: 10.1016/j.bbamcr.2008.01.010. Epub 2008 Jan 26.
5
Wobble splicing reveals the role of the branch point sequence-to-NAGNAG region in 3' tandem splice site selection.摆动剪接揭示了分支点序列到NAGNAG区域在3'串联剪接位点选择中的作用。
Mol Cell Biol. 2007 Aug;27(16):5835-48. doi: 10.1128/MCB.00363-07. Epub 2007 Jun 11.
6
Molecular characterization of the cystic fibrosis transmembrane conductance regulator gene in congenital absence of the vas deferens.先天性输精管缺如中囊性纤维化跨膜传导调节因子基因的分子特征分析
Genet Med. 2007 Mar;9(3):163-72. doi: 10.1097/gim.0b013e3180318aaf.
7
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.无义介导的mRNA降解影响无义转录本水平,并决定囊性纤维化患者对庆大霉素的反应。
J Clin Invest. 2007 Mar;117(3):683-92. doi: 10.1172/JCI28523. Epub 2007 Feb 8.
8
Alternative splicing at NAGNAG acceptors: simply noise or noise and more?NAGNAG受体处的可变剪接:仅仅是噪音还是还有更多?
PLoS Genet. 2006 Nov 24;2(11):e207; author reply e208. doi: 10.1371/journal.pgen.0020207.
9
Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing.NAGNAG受体中的单核苷酸多态性对可变剪接的变异具有高度预测性。
Am J Hum Genet. 2006 Feb;78(2):291-302. doi: 10.1086/500151. Epub 2005 Dec 22.
10
Alternative splicing regulation at tandem 3' splice sites.串联3'剪接位点处的可变剪接调控
Nucleic Acids Res. 2006 Jan 3;34(1):23-31. doi: 10.1093/nar/gkj408. Print 2006.